The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
DataMeds AI, Inc. (NASDAQ: MEDS) says its Corexa Pharmacy generated more than $1 million in preliminary, unaudited revenue in September 2026. The company also reported that September revenue was more than 66% higher than July 2026 revenue. These are company-reported monthly figures, not audited financial results or a disclosed revenue breakdown.
What Corexa Pharmacy reported
In a company announcement dated October 1, 2026, DataMeds AI attributed the September result to Corexa Pharmacy. The figure is explicitly described as preliminary and unaudited, so it may change when finalized accounts or later filings become available.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Sharp 8-Digit Dual Power Pocket Calculator, Gray/Blue (EL-243SB) | $10.99 | Buy on Amazon |
| Measure | Reported result | Qualification |
|---|---|---|
| Corexa Pharmacy revenue | More than $1 million | September 2026; preliminary and unaudited; company-reported |
| Change versus July | More than 66% increase | Company-reported comparison; July dollar revenue was not disclosed |
DataMeds did not publish Corexa’s July revenue, a split between prescription dispensing and adjunct products, or Corexa-specific profit and margin figures. Those missing values cannot be calculated from the announcement.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What the company says drove the increase
Management identified three factors behind the growth, without assigning a dollar amount or percentage to any of them:
#1 Best Overall
- PROTECTIVE HINGED COVER: Features a hinged, hard cover that protects the keys and display when stored, making this handheld calculator durable and easy to carry safely.
- DUAL-POWER SOURCE: Runs on solar energy with a battery backup, ensuring consistent and reliable use in any lighting condition or environment.
- LCD SCREEN SIZE: The 2-inch screen size, 8-digit LCD screen clearly shows each digit, helping to prevent reading errors and making numbers easy to read at a glance.
- CONVENIENT FUNCTION KEYS: Includes a 3-key independent memory, square root key, change sign key, automatic power down, and more to provide efficient, reliable everyday math.
- TRUSTED BY WORKPLACES FOR DECADES: Sharp has been a dependable name in office calculation for generations — practical tools built around the way people actually work.
- An expanding retail customer base
- More prescriptions filled
- Launches of Tollo Health proprietary dietary supplements and medical foods
This is management’s explanation rather than an independently measured driver analysis. The announcement does not establish how much revenue came from prescriptions, supplements, medical foods, or any other category.
Where Corexa fits in DataMeds AI
Corexa Pharmacy is a division of wholly owned subsidiary Corexa Health. DataMeds describes Corexa Health as providing pharmacy dispensing and related services, including distribution of selected Tollo Health products under a wholesale distribution arrangement.
The company also says its Health Lives Here mobile application offers Corexa Pharmacy as a fulfillment option for telehealth prescriptions. That describes a channel and service relationship; the release does not quantify how much revenue came through the application.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Tollo Health products mentioned by the company
DataMeds links Corexa’s activity with Tollo Health supplements and medical foods. The company’s media materials identify:
- Tollovid as a dietary supplement
- Galectovid as a medical food
- Forzet as a medical food
An earlier company update said these products were available through Corexa-related online channels and that Amazon availability was forthcoming. That statement does not verify a current Amazon listing, seller, or affiliate relationship. Readers searching for the product should confirm that a current listing exists and should not treat the revenue announcement as evidence of efficacy or a recommendation for medical use.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Expansion plans and forward-looking claims
DataMeds said Corexa’s physical location was being upgraded as a flagship model for a network it described as covering more than 6,500 independent pharmacies. The company also characterized continued growth, future product demand, prescription fulfillment, location upgrades, and partnerships as forward-looking matters whose actual results may differ materially.
Accordingly, the flagship concept and network ambition are plans, not demonstrated rollout results. The announcement provides no financial estimate for the upgrades or their potential effect on revenue.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchHow to interpret the $1 million figure
- It is a single-month figure for September 2026, not quarterly or annual consolidated DataMeds revenue.
- It is preliminary and unaudited.
- The more-than-66% comparison is versus July 2026, but the July dollar amount is not stated.
- No independent verification, revenue mix, margin, or profit result was provided.
Gerald Commissiong, identified as DataMeds’ interim co-CEO, said: “Having completed the rebranding of Corexa Pharmacy in the first month of the third quarter of 2026, we are very pleased to already see such substantial growth so quickly.” The quotation expresses management’s view; it does not guarantee that the growth rate will continue.
The Bottom Line
DataMeds AI reported that Corexa Pharmacy exceeded $1 million in preliminary, unaudited September 2026 revenue, more than 66% above July. The announcement supports a strong company-reported monthly result, but it does not yet show audited revenue, profitability, product mix, or independently verified growth drivers.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
